Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo

1374.279 - 1394.785 Dr. Andrea Apolo

And then while my trial was ongoing, I was using pembrolizumab. Then while we were waiting to date, I was using nivolumab. And now I've gone back to using pembrolizumab. And the reason I like pembrolizumab, I like them both, to be honest. They're both pretty easy to use. The nivolumab, the trial was done every two weeks. But I use them monthly because that's an FDA-approved dosing.